JFLLIFE

JFL Life Sciences Share Price

 

Stock Hit Lower Circuit

 

Start SIP in JFLLIFE

Start SIP

Performance

  • Low
  • ₹13
  • High
  • ₹13
  • 52 Week Low
  • ₹11
  • 52 Week High
  • ₹31
  • Open Price₹13
  • Previous Close₹14
  • Volume6,000

Investment Returns

  • Over 1 Month + 11.76%
  • Over 3 Month + 2.31%
  • Over 6 Month -12.21%
  • Over 1 Year -58.89%

Smart Investing Starts Here Start SIP with JFL Life Sciences for Steady Growth!

Invest Now

JFL Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 10.6
  • PEG Ratio
  • -0.5
  • Market Cap Cr
  • 44
  • P/B Ratio
  • 1
  • Average True Range
  • 0.6
  • EPS
  • 1.07
  • Dividend Yield
  • 0
  • MACD Signal
  • -0
  • RSI
  • 54.57
  • MFI
  • 65.77

JFL Life Sciences Financials

JFL Life Sciences Technicals

EMA & SMA

Current Price
₹13.30
-0.7 (-5%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹12.81
  • 50 Day
  • ₹12.95
  • 100 Day
  • ₹13.99
  • 200 Day
  • ₹15.59

Resistance and Support

13.3 Pivot Speed
  • R3 13.30
  • R2 13.30
  • R1 13.30
  • S1 13.30
  • S2 13.30
  • S3 13.30

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Jfl Life Sciences has an operating revenue of Rs. 74.47 Cr. on a trailing 12-month basis. An annual revenue growth of 74% is outstanding, Pre-tax margin of 7% is okay, ROE of 10% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 166 indicates it belongs to a poor industry group of Medical-Whlsle Drg/Suppl and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

JFL Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-11 Quarterly Results & Others To consider other business matters. issue in the ratio of 2:1 of Rs. 10/-.
2025-09-01 Others To consider other business matters. issue in the ratio of 2:1 of Rs. 10/-.
2025-08-11 Quarterly Results & Others To consider other business matters. issue in the ratio of 2:1 of Rs. 10/-.
2025-05-19 Audited Results
2025-04-08 Quarterly Results & Others To consider other business matters. issue in the ratio of 2:1 of Rs. 10/-.
Date Purpose Remarks
2024-09-24 Bonus Rs.0.00 issue in the ratio of 2:1 of Rs. 10/-.

JFL Life Sciences F&O

JFL Life Sciences Shareholding Pattern

67.47%
28.88%
3.65%

About JFL Life Sciences

  • NSE Symbol
  • JFLLIFE
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Smiral Ashwinkumar Patel
  • ISIN
  • INE0LA901015

Similar Stocks to JFL Life Sciences

JFL Life Sciences FAQs

JFL Life Sciences share price is ₹13 As on 26 December, 2025 | 21:25

The Market Cap of JFL Life Sciences is ₹43.9 Cr As on 26 December, 2025 | 21:25

The P/E ratio of JFL Life Sciences is 10.6 As on 26 December, 2025 | 21:25

The PB ratio of JFL Life Sciences is 1 As on 26 December, 2025 | 21:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23